O4‐03‐04: Type 3 Diabetes in Alzheimer's Disease: Ab‐Mediated Inhibition of EG5/Kinesin 5 Leads to Insulin Receptor and Glucose Transporter Mis‐Localization and Dysfunction. (1st July 2016)